Gene Therapy and Goggles Restore Limited Vision in Blind Patients

In an international trial of ten patients with advanced retinitis pigmentosa, a combination of optogenetic gene therapy (ChrimsonR) and camera-equipped goggles made seven participants more sensitive to light, with six showing clinically meaningful improvement. Four of eight who completed visual behavior tests improved at detecting objects, though reading and face recognition remained impossible.

• 7 of 10 patients became more light-sensitive; 6 had clinically meaningful gains
• 4 of 8 tested participants improved at detecting or locating objects
• Each patient received one injection of the amber-light-sensitive ChrimsonR gene
• Reading and face recognition remained out of reach; safety was the primary endpoint